text.skipToContent text.skipToNavigation

Nova Biomedical SOLUTION DEPROTEINIZING AUTOSAMPLER BP F 46850

Nova Biomedical -- Item TECPIM000412384
Please add to cart & request for quote to see the price
Reserve Now    

The Nova Biomedical SOLUTION DEPROTEINIZING AUTOSAMPLER BP F 46850 is a specialized reagent used for deproteinizing samples in an autosampler system, ensuring accurate and reliable results in biochemical analysis.

Benefits/Advantages:

  • Ensures thorough removal of proteins from samples, preventing interference with analysis.
  • Facilitates smooth operation of autosampler systems, minimizing downtime and increasing efficiency.
  • Maintains sample integrity and preserves the accuracy of test results.

Product Details

Model
Product Type Consumables
Part Number 46850
Brand Nova Biomedical
Gross Dimensions (WxDxH cm)
Net Dimensions (WxDxH cm)
Gross Weight (kg)
Net Weight (kg)

More options are available. Please contact us for more information.

More options are available. Please contact us for more information.

Nova Biomedical

Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers.

 

Nova Biomedical is the world technology leader in the development of fast, whole blood analyzers to support the care of hospitalized and critically ill patients. Nova analyzers offer the most extensive stat test menus and deliver results in the shortest time at the lowest costs. Nova also provides handheld meter-and-strip based measuring systems for glucose, ketone, lactate, and creatinine point-of-care testing. Whether testing is performed in the central laboratory or in emergency, surgical, critical, or respiratory care areas, Nova analyzers can help to improve patient outcomes while reducing the cost of care.

 

With manufacturing facilities in Waltham and Billerica, Massachusetts, Belo Horizonte, Brazil and in Taipei, Taiwan, Nova is one of the 25 largest in vitro diagnostic companies in the world and the largest privately owned in vitro diagnostic company in the United States.